LONDON (Alliance News) - Sphere Medical Holding PLC Monday said a study at Great Ormond Street Hospital for Children to evaluate the use of its Pelorus 1500 analyser to monitor accurately propofol levels during paediatric spinal surgery on anaesthetised children had now ended.
It said an initial assessment of the results indicated that current dosing models can lead to significant variability in the concentration of drug present for this patient group, and that a detailed analysis of the study that's now being carried out is intended to be the basis for investigating an improved approach to dosing children in certain surgical procedures.
In addition, Sphere Medical is also collaborating with the Department of Anesthesiology at the University Medical Centre Groningen in the Netherlands and clinicians are investigating the real time adaptation of dosing models to the individual patient using rapid propofol measurements provided by the Pelorus 1500 system, it said in a statement.
"This study at Great Ormond Street Hospital for Children provides further evidence that the use of the Pelorus 1500 for the rapid measurement of propofol will ultimately provide personalisation of propofol dosing to the patient during surgery," Chief executive Stuart Hendry said in a statement.
The company's shares were down 5.6% at 34 pence Monday morning.
By Steve McGrath; stevemcgrath@alliancenews.com; @SteveMcGrath1
Copyright 2013 Alliance News Limited. All Rights Reserved.